Congress Trades
Latest disclosures
| Chamber | Transaction Date | Member | Owner | Asset ▼ | Action | Amount | Ticker | Δ Since Trade |
|---|---|---|---|---|---|---|---|---|
| Senate | Sep. 6, 2024 | John Boozman | Joint | Aberdeen Standard Physical Platinum Shares ETF | PURCHASE | $1,001 - $15,000 | PPLT | ▲ +75.10% |
| Senate | Sep. 6, 2024 | John Boozman | Joint | Aberdeen Standard Physical Palladium Shares ETF | PURCHASE | $1,001 - $15,000 | PALL | ▲ +57.02% |
| House | Mar. 27, 2024 | William R. Keating | ABBVIE INC NOTE CALL MAKE WHOLE 5.05000% 03/15/2034 | PURCHASE | $15,001 - $50,000 | — | ||
| Senate | Mar. 27, 2024 | William R. Keating | ABBVIE INC NOTE CALL MAKE WHOLE 5.05000% 03/15/2034 | PURCHASE | $15,001 - $50,000 | — | ||
| House | Mar. 27, 2024 | William R. Keating | ABBVIE INC NOTE CALL MAKE WHOLE 5.05000% 03/15/2034 | PURCHASE | $15,001 - $50,000 | — | ||
| House | Apr. 3, 2025 | Josh Gottheimer | Joint | AbbVie Inc. Common Stock | PURCHASE | $1,001 - $15,000 | ABBV | ▲ +13.20% |
| House | Nov. 10, 2023 | John James | AbbVie Inc. Common Stock | PURCHASE | $1,001 - $15,000 | ABBV | ▲ +64.69% | |
| Senate | Jan. 19, 2024 | Tommy Tuberville | Joint | AbbVie Inc. Common Stock | SALE (FULL) | $1,001 - $15,000 | ABBV | ▲ +38.53% |
| Senate | Mar. 30, 2022 | Tommy Tuberville | Joint | AbbVie Inc. Common Stock | PURCHASE | $1,001 - $15,000 | ABBV | ▲ +39.39% |
| Senate | Jan. 21, 2022 | Tommy Tuberville | Joint | AbbVie Inc. Common Stock | SALE (FULL) | $1,001 - $15,000 | ABBV | ▲ +72.94% |
| House | Jul. 2, 2024 | Kathy Manning | Spouse | AbbVie Inc. Common Stock | PURCHASE | $1,001 - $15,000 | ABBV | ▲ +37.53% |
| House | Apr. 8, 2025 | Rob Bresnahan | AbbVie Inc. Common Stock | SALE (FULL) | $1,001 - $15,000 | ABBV | ▲ +29.93% | |
| Senate | Apr. 3, 2023 | Tommy Tuberville | Joint | AbbVie Inc. Common Stock | SALE (PARTIAL) | $1,001 - $15,000 | ABBV | ▲ +42.28% |
| House | Sep. 4, 2024 | John James | AbbVie Inc. Common Stock | SALE (FULL) | $1,001 - $15,000 | ABBV | ▲ +15.86% | |
| House | Apr. 10, 2024 | Michael C. Burgess | AbbVie Inc. Common Stock | SALE (PARTIAL) | $1,001 - $15,000 | ABBV | ▲ +35.04% | |
| Senate | Jan. 18, 2022 | Thomas R. Carper | Spouse | AbbVie Inc. Common Stock | SALE (PARTIAL) | $1,001 - $15,000 | ABBV | ▲ +66.87% |
| Senate | Apr. 3, 2024 | Tommy Tuberville | Joint | AbbVie Inc. Common Stock | PURCHASE | $1,001 - $15,000 | ABBV | ▲ +28.71% |
| House | Apr. 17, 2025 | Josh Gottheimer | Joint | AbbVie Inc. Common Stock | SALE (FULL) | $1,001 - $15,000 | ABBV | ▲ +31.94% |
| House | Jul. 22, 2025 | Lisa McClain | Spouse | AbbVie Inc. Common Stock | PURCHASE | $1,001 - $15,000 | ABBV | ▲ +21.99% |
| House | Apr. 1, 2025 | Josh Gottheimer | Joint | AbbVie Inc. Common Stock | PURCHASE | $1,001 - $15,000 | ABBV | ▲ +10.66% |
| Senate | Oct. 17, 2023 | Tommy Tuberville | Joint | AbbVie Inc. Common Stock | PURCHASE | $1,001 - $15,000 | ABBV | ▲ +53.00% |
| House | Jul. 22, 2025 | Lisa McClain | Spouse | AbbVie Inc. Common Stock | SALE (PARTIAL) | $1,001 - $15,000 | ABBV | ▲ +21.99% |
| House | Jan. 15, 2025 | Jared Moskowitz | AbbVie Inc (2) | PURCHASE | $1,001 - $15,000 | ABBV | ▲ +33.21% | |
| Senate | Dec. 6, 2018 | Jerry Moran | Spouse | AbbVie Inc. | PURCHASE | $1,001 - $15,000 | ABBV | ▲ +152.68% |
| Senate | Jul. 9, 2020 | Thomas R. Carper | Spouse | AbbVie Inc. | SALE (PARTIAL) | $1,001 - $15,000 | ABBV | ▲ +133.05% |
| Senate | Jul. 15, 2019 | David Perdue | Joint | AbbVie Inc. | SALE (PARTIAL) | $15,001 - $50,000 | ABBV | ▲ +224.82% |
| Senate | Apr. 14, 2020 | Kelly Loeffler | Spouse | AbbVie Inc. | SALE (FULL) | $250,001 - $500,000 | ABBV | ▲ +177.91% |
| Senate | Jan. 7, 2016 | David Perdue | Joint | AbbVie Inc. | PURCHASE | $1,001 - $15,000 | ABBV | ▲ +298.97% |
| Senate | Aug. 21, 2020 | Jerry Moran | Self | AbbVie Inc. | SALE (FULL) | $1,001 - $15,000 | ABBV | ▲ +140.62% |
| Senate | Nov. 20, 2020 | Thomas R. Carper | Spouse | AbbVie Inc. | PURCHASE | $1,001 - $15,000 | ABBV | ▲ +126.35% |
Last updated: Oct 24, 07:12